These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 33719549)

  • 1. Newer insights into the pathobiological and pharmacological basis of the sex disparity in patients with pulmonary arterial hypertension.
    Hye T; Dwivedi P; Li W; Lahm T; Nozik-Grayck E; Stenmark KR; Ahsan F
    Am J Physiol Lung Cell Mol Physiol; 2021 Jun; 320(6):L1025-L1037. PubMed ID: 33719549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-dependent remodeling of right ventricular function in a rat model of pulmonary arterial hypertension.
    Kwan ED; Hardie BA; Garcia KM; Mu H; Wang TM; Valdez-Jasso D
    Am J Physiol Heart Circ Physiol; 2024 Aug; 327(2):H351-H363. PubMed ID: 38847755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of mesenchymal stem cell delivery via a novel cardiac bioscaffold on right ventricles of pulmonary arterial hypertensive rats.
    Schmuck EG; Hacker TA; Schreier DA; Chesler NC; Wang Z
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1005-H1013. PubMed ID: 30822119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct right ventricle remodeling in response to pressure overload in the rat.
    Mendes-Ferreira P; Santos-Ribeiro D; Adão R; Maia-Rocha C; Mendes-Ferreira M; Sousa-Mendes C; Leite-Moreira AF; Brás-Silva C
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H85-95. PubMed ID: 27199115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct and indirect protection of right ventricular function by estrogen in an experimental model of pulmonary arterial hypertension.
    Liu A; Schreier D; Tian L; Eickhoff JC; Wang Z; Hacker TA; Chesler NC
    Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H273-83. PubMed ID: 24906919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrastructural Changes of the Right Ventricular Myocytes in Pulmonary Arterial Hypertension.
    Shults NV; Kanovka SS; Ten Eyck JE; Rybka V; Suzuki YJ
    J Am Heart Assoc; 2019 Mar; 8(5):e011227. PubMed ID: 30807241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
    Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary Artery Hypertension Model in Rats by Monocrotaline Administration.
    Bueno-Beti C; Sassi Y; Hajjar RJ; Hadri L
    Methods Mol Biol; 2018; 1816():233-241. PubMed ID: 29987824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urocortin-2 improves right ventricular function and attenuates pulmonary arterial hypertension.
    Adão R; Mendes-Ferreira P; Santos-Ribeiro D; Maia-Rocha C; Pimentel LD; Monteiro-Pinto C; Mulvaney EP; Reid HM; Kinsella BT; Potus F; Breuils-Bonnet S; Rademaker MT; Provencher S; Bonnet S; Leite-Moreira AF; Brás-Silva C
    Cardiovasc Res; 2018 Jul; 114(8):1165-1177. PubMed ID: 29584808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension.
    Sun XQ; Peters EL; Schalij I; Axelsen JB; Andersen S; Kurakula K; Gomez-Puerto MC; Szulcek R; Pan X; da Silva Goncalves Bos D; Schiepers REJ; Andersen A; Goumans MJ; Vonk Noordegraaf A; van der Laarse WJ; de Man FS; Bogaard HJ
    Am J Respir Cell Mol Biol; 2021 Mar; 64(3):331-343. PubMed ID: 33264068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension.
    Akazawa Y; Okumura K; Ishii R; Slorach C; Hui W; Ide H; Honjo O; Sun M; Kabir G; Connelly K; Friedberg MK
    J Appl Physiol (1985); 2020 Aug; 129(2):238-246. PubMed ID: 32644912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial Hypertension.
    Omura J; Habbout K; Shimauchi T; Wu WH; Breuils-Bonnet S; Tremblay E; Martineau S; Nadeau V; Gagnon K; Mazoyer F; Perron J; Potus F; Lin JH; Zafar H; Kiely DG; Lawrie A; Archer SL; Paulin R; Provencher S; Boucherat O; Bonnet S
    Circulation; 2020 Oct; 142(15):1464-1484. PubMed ID: 32698630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary vascular mechanical consequences of ischemic heart failure and implications for right ventricular function.
    Philip JL; Murphy TM; Schreier DA; Stevens S; Tabima DM; Albrecht M; Frump AL; Hacker TA; Lahm T; Chesler NC
    Am J Physiol Heart Circ Physiol; 2019 May; 316(5):H1167-H1177. PubMed ID: 30767670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excitation-contraction coupling and relaxation alteration in right ventricular remodelling caused by pulmonary arterial hypertension.
    Antigny F; Mercier O; Humbert M; Sabourin J
    Arch Cardiovasc Dis; 2020 Jan; 113(1):70-84. PubMed ID: 31924541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right ventricular diastolic impairment in patients with pulmonary arterial hypertension.
    Rain S; Handoko ML; Trip P; Gan CT; Westerhof N; Stienen GJ; Paulus WJ; Ottenheijm CA; Marcus JT; Dorfmüller P; Guignabert C; Humbert M; Macdonald P; Dos Remedios C; Postmus PE; Saripalli C; Hidalgo CG; Granzier HL; Vonk-Noordegraaf A; van der Velden J; de Man FS
    Circulation; 2013 Oct; 128(18):2016-25, 1-10. PubMed ID: 24056688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex, Gender, and Sex Hormones in Pulmonary Hypertension and Right Ventricular Failure.
    Hester J; Ventetuolo C; Lahm T
    Compr Physiol; 2019 Dec; 10(1):125-170. PubMed ID: 31853950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RV pressure overload: from hypertrophy to failure.
    van der Bruggen CEE; Tedford RJ; Handoko ML; van der Velden J; de Man FS
    Cardiovasc Res; 2017 Oct; 113(12):1423-1432. PubMed ID: 28957530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension.
    Mulvaney EP; Reid HM; Bialesova L; Bouchard A; Salvail D; Kinsella BT
    BMC Pulm Med; 2020 Apr; 20(1):85. PubMed ID: 32252727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension in women.
    Pugh ME; Hemnes AR
    Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1549-58. PubMed ID: 21090930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic Regulation of Pulmonary Arterial Hypertension-Induced Vascular and Right Ventricular Remodeling: New Opportunities?
    Kocken JMM; da Costa Martins PA
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.